30085-34-8 Usage
Derivative of
Hydroxyurea
Used for
Treatment of various types of cancer and sickle cell disease
Studied for
Potential anticancer and antiproliferative activities
Investigated for
Anti-inflammatory and immunomodulatory properties
Researched for
Inhibition of growth of certain types of bacteria and fungi
Further research needed
To fully understand the potential therapeutic applications of 1-(4-chlorophenyl)-3-hydroxyurea
Check Digit Verification of cas no
The CAS Registry Mumber 30085-34-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,0,8 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 30085-34:
(7*3)+(6*0)+(5*0)+(4*8)+(3*5)+(2*3)+(1*4)=78
78 % 10 = 8
So 30085-34-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H7ClN2O2/c8-5-1-3-6(4-2-5)9-7(11)10-12/h1-4,12H,(H2,9,10,11)
30085-34-8Relevant articles and documents
Synthesis of substituted N-hydroxyureas via the in situ generation of t-butoxy isocyanate
Krause, Josef G.,Leskiw, Brian D.,Emery, Michelle L.,McGahan, Megan E.,McCourt, Mary P.,Priefer, Ronny
body text, p. 3568 - 3570 (2010/08/07)
Treatment of primary and secondary amines with tert- butylmesitylenesulfonoxycarbamate and a base afforded tert-butoxyurea, which when treated with an acid ultimately yielded substituted N-hydroxyureas. It is proposed that this proceeded via the generation of t-butoxy isocyanate in situ. This method allows for the synthesis of both mono and disubstituted N-hydroxyureas.
REACTION OF TRISUBSTITUTED UREAS WITH AMINO-CONTAINING COMPOUNDS
Veis, I.,Ruff, E.,Otvosh, L.
, p. 694 - 696 (2007/10/02)
-